本文選題：漢防己甲素固體分散體 + 分散片�。� 參考：《中國(guó)藥房》2016年07期

【摘要】：目的:優(yōu)選漢防己甲素固體分散片的制備處方。方法:采用直接壓片法制備漢防己甲素固體分散片。采用單因素試驗(yàn)篩選常用輔料,以崩解時(shí)間為指標(biāo),以交聯(lián)聚乙烯吡咯烷酮(PVPP)用量、乳糖-微晶纖維素比例、微粉硅膠用量為因素,采用正交試驗(yàn)對(duì)處方進(jìn)行優(yōu)化,并進(jìn)行驗(yàn)證。比較所制片劑與漢防己甲素普通片的溶出度,測(cè)定最優(yōu)處方所制片劑的含量。結(jié)果:最優(yōu)處方為以9.5%PVPP為崩解劑、乳糖-微晶纖維素(1∶2)為填充劑,混勻,加入1%的微粉硅膠為潤(rùn)滑劑,粉末直接壓片。所制3批片劑的崩解時(shí)間分別為79、81、78 s,占標(biāo)示量百分含量分別為98.66%、99.24%、99.85%,RSD分別為0.72%、1.16%、1.33%。與漢防己甲素普通片比較,所制片劑的溶出度明顯提高。結(jié)論:成功制得漢防己甲素固體分散片,且處方合理、重復(fù)性好。
[Abstract]:Objective: to optimize the preparation of Tetrandrine solid dispersible tablets. Methods: Tetrandrine solid dispersible tablets were prepared by direct pressing method. A single factor test was used to screen common excipients. The formulation was optimized by orthogonal test with the dosage of crosslinked polyvinylpyrrolidone (PVPP), the ratio of lactose to microcrystalline cellulose and the amount of silica gel. And verify it. The dissolution of the tablets was compared with that of Tetrandrine tablets. Results: the optimal formulation was as follows: 9.5%PVPP as disintegrating agent, lactose microcrystalline cellulose 1: 2) as filler, mixed evenly, 1% silica gel as lubricant, powder pressed directly. The disintegration time of the three tablets was 79 ~ 81g / 78 s, and the percent content of the three tablets was 98.66 ~ 99.24 ~ 99.85%, respectively. The RSD was 0.72% and 1.16% ~ 1.33%, respectively. Compared with Tetrandrine tablets, the dissolution of the tablets was significantly improved. Conclusion: Tetrandrine solid dispersible tablets were successfully prepared and the prescription was reasonable and reproducible.
【作者單位】： 廣西壯族自治區(qū)食品藥品審評(píng)查驗(yàn)中心;廣西醫(yī)科大學(xué)藥學(xué)院;
【基金】：廣西科學(xué)研究與技術(shù)開(kāi)發(fā)計(jì)劃項(xiàng)目(No.桂科合1346011-22) 南寧市科學(xué)研究與技術(shù)開(kāi)發(fā)計(jì)劃項(xiàng)目(No.20123117)
【分類(lèi)號(hào)】：R943

【相似文獻(xiàn)】

相關(guān)期刊論文 前2條

1 余潛;王卓纓;肖大偉;;半乳糖化白蛋白漢防己甲素納米粒的合成[J];上海中醫(yī)藥雜志;2009年06期

2 ;[J];;年期

相關(guān)會(huì)議論文 前1條

1 殷愛(ài)玲;郭立瑋;;SPG膜乳化法制備漢防己甲素肺靶向微球的工藝及釋放研究[A];第五屆全國(guó)醫(yī)藥行業(yè)膜分離技術(shù)應(yīng)用研討會(huì)論文集[C];2012年

相關(guān)碩士學(xué)位論文 前1條

1 樊婷;漢防己甲素干粉吸入劑的藥學(xué)研究[D];蘇州大學(xué);2013年

，

本文編號(hào)：1832856